Copyright 2024
| PMID | Allele | Disease | Population | Drug Names | SNP | Class | Sentence |
|---|---|---|---|---|---|---|---|
| 12044056 | HLA-DQB1 (HLA-DQB1) | hematopoietic stem cell transplantation | NA | NA | NA | unclassified | |
| the selection of human leukocyte antigen (hla) compatible unrelated donors for hematopoietic stem cell transplantation (hsct) is based on the direct genotyping of hla class i and class ii alleles (hla-a, -b, -c, -drb1, -dqb1 loci). | |||||||
| 12216952 | HLA (HLA) | hematopoietic stem cell transplantation | Caucasian | NA | NA | unclassified | |
| as compared to hematopoietic stem cell transplantation (hsct) with hla genotypically identical donors, phenotypically matched unrelated hsct is associated with lower survival. | |||||||
| 12416733 | HLA MISMATCHED (HLA-MISMATCHED) | hematopoietic stem cell transplantation | NA | NA | NA | unclassified | |
| if this concept holds true, hla-mismatched hematopoietic stem cell transplantation would be more feasible among haploidentical family members mutually linked with feto-maternal microchimerism. | |||||||
| 12430917 | HLA (HLA) | hematopoietic stem cell transplantation | NA | NA | NA | unclassified | |
| matching of patient and unrelated donor for hla molecules significantly decreases the probability of graft rejection, graft vs. host disease, and transplant-related mortality in hematopoietic stem cell transplantation. | |||||||
| 12513720 | HLA (HLA) | hematopoietic stem cell transplantation | NA | NA | NA | unclassified | |
| [selection of donor in mismatched hematopoietic stem cell transplantation by creg, residue match and hla three-dimensional structure]. | |||||||
| 12601275 | HUMAN LEUKOCYTE ANTIGEN (HUMAN LEUKOCYTE ANTIGEN) | hematopoietic stem cell transplantation | NA | NA | NA | unclassified | |
| nonmyeloablative hematopoietic stem cell transplantation using human leukocyte antigen matched sibling donor, which carries a relatively low risk of transplant-related complications and can result in impressive antitumor responses, may benefit older patients and patients with preexisting organ impairment. | |||||||
| 12618895 | HLA IDENTICAL (HLA-IDENTICAL) | prednisolone | NA | paclitaxel | NA | negative | |
| NA | |||||||
| 12714500 | HLA IDENTICAL (HLA-IDENTICAL) | hematopoietic stem cell transplantation | NA | NA | NA | unclassified | |
| allogeneic hematopoietic stem cell transplantation from family members other than hla-identical siblings over the last decade (1991-2000). | |||||||
| 12714500 | HLA MISMATCHED (HLA-MISMATCHED) | hematopoietic stem cell transplantation | NA | NA | NA | unclassified | |
| the reported outcome of hematopoietic stem cell transplantation (hsct) from hla-mismatched family members has been inconsistent. | |||||||
| 14648027 | HLA IDENTICAL (HLA-IDENTICAL) | cyclophosphamide | NA | fludarabine | NA | only_studied | |
| NA | |||||||
Copyright 2024